Indefinite Delivery Contract 75N93025D00006
Award Date
9/15/25
Last Date to Order
9/14/32
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Aapharmasyn LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to The Emmes Company LLC on September 1, 2021. With a potential value of $545,452,906 over seven years, this single award IDC supports NIAID's research programs through a broad range of services. Task Order 1 issued under the contract is a firm fixed price order valued at $2,000 to satisfy minimum requirements. Performance will take place in Potomac, MD from September 1, 2021 through August 31,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract worth up to $107,274,471 to provide preclinical development support for candidate products and drug development activities related to HIV, hepatitis B and C, and tuberculosis. This multiple-award IDIQ contract has a 7-year period of performance from October 2020 to October 2027. The scope...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Lovelace Biomedical Research Institute to provide preclinical development support for candidate products and drug development activities for HIV, hepatitis, and tuberculosis. The 7-year, $107.3 million contract covers a range of services across seven task areas, including in vitro screening,...
The federal contract IDV award is for Chemistry, Manufacturing, and Control (CMC) and related services to support the development of drug products for the National Center for Advancing Translational Sciences (NCATS), a civilian agency. This is a multiple award, indefinite delivery contract with a $49,885,703 ceiling value and a period of performance through July 2031. The prime contractor, Alchem Laboratories Corporation, is a for-profit pharmaceutical manufacturer that will provide a broad...
The Department of Health and Human Services National Institutes of Health (NIH) awarded an Indefinite Delivery Contract (IDC) to Alchem Laboratories Corporation, doing business as Alchem Laboratories Corp, to provide drug formulation and manufacturing services. The $45,000,250 multiple-award IDC was partially set aside for small businesses and has a period of performance through September 2024. Under this IDC, Alchem Laboratories has been issued task orders to synthesize non-GMP small molecule...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded this multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide preclinical development support for candidate products and drug development activities related to HIV, hepatitis B, hepatitis C, and tuberculosis. The $107.3 million contract has a 7-year period of performance and encompasses seven task areas, including in vitro testing, synthesis of...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
This is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The base contract has a potential value of $124,500,000 and a period of performance through September 28, 2028. The purpose is to provide NIAID Preclinical Development Support...
The federal contract IDV award is for an Indefinite Delivery Contract with a ceiling value of $146,300,000 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is focused on providing pre-clinical models of infectious diseases to support research, development, and evaluation of medical countermeasures such as therapeutics, vaccines, and diagnostics. The contract has a single award to...